Longboat

Patient advocacy groups are a powerful force in drug development. Check out our latest blog.

The Power of Patient Advocacy in Drug Development This blog outlines the origins and rise of patient advocacy groups, discussing the milestones in the FDA's acceptance of these groups.

As study teams work to increase protocol compliance, participant retention, and future recruitment, focusing on creating a positive experience during the trial can reap many benefits. Check out or latest blog:

3 Strategies to Successfully Engage Participants in Your Trial A positive participant experience underpins the success of any clinical trial. Leverage these key strategies to ensure success.

News stories in the past year were dominated by COVID-19 vaccine development. While those involved in the clinical research industry understand the nuances to a clinical trial, too few of the general public truly understand the intricacies of vaccine development to see the bigger picture.

The Impact of Public Perception of Clinical Research News stories in the past year were dominated by COVID-19 vaccine development. Everyone’s interested in the story, but how many know the ins and outs of vaccine development and how that affects research?

In order to achieve patient centricity, clinical trials need to be site-centric first. With this mindset, what does it mean to be site-centric, and how does that improve the overall participation experience? Check out our latest blog.

To Be Patient-centric, Be Site-centric What does it mean to be “site-centric” as a step toward patient centricity? Patient centricity has long been a key goal in healthcare, as well as in clinical research.

Check out this excerpt from our eBook ‘How to Improve Site Compliance’.

Are You Ready for an Unplanned Site Inspection? A centralized repository for hosting this information, with version control management and the ability to generate customized reports, can facilitate this aspect of inspection preparation.

Ahead of Rare Disease Day, we are taking a look at the Orphan Drug Act, which has helped to bring drugs and biologics to market in the fight against rare diseases.

Responding to Rare Diseases—The Orphan Drug Act in Action Ahead of Rare Disease Day, we are taking a look at the Orphan Drug Act, which has helped to bring drugs and biologics to market in the fight against rare diseases.

FDA annually reports the top most commonly cited violations in through their BIMO program. Let’s take a look at some of the most common.

A Look at the FDA's Report on Top Clinical Trial Site Violations The FDA inspects clinical trial sites and produces warning letters for violations found. FDA annually reports the top most commonly cited violations in clinical trials through their BIMO program. Let’s take a look at some of the most common.

In a recent blog post, we talked about the diversity issue in clinical trials and the negative impact it has on research. Now, let’s address some practical ways pharma companies can apply to improve clinical trial diversity.

Diversity in Clinical Trials - 4 Practical Ways We Can Make it Happen Let’s address some practical ways pharma companies can apply to improve clinical trial diversity.

Check out this excerpt from our eBook 'The Power of Getting Everyone in Your Clinical Trial to Work as One Team'. https://hubs.ly/H0DZPyV0

What tools and tech can help build a better sense of team in a clinical trial? Technology can lessen the burden on on-site staff, enabling them to maximize the limited face-to-face time they have with their patients.

Successful teamwork involves much more than healthcare professionals complying with the protocol or study managers running and monitoring the trial. Check out this excerpt from our eBook.

How and Why You Need a "Team View" for Clinical Trial Operations Successful teamwork involves much more than healthcare professionals complying with the protocol or study managers running and monitoring the trial.

Happy holidays to you and yours from all the team at Longboat by Advarra!

As the pharma industry worked to identify and create a safe and effective COVID-19 vaccine at warp speed, this urgency highlighted one of the greatest challenges affecting modern pharmaceutical research, a lack of diversity in clinical trials.

Diversity in Clinical Trials - The Challenges Highlighted by COVID-19 Companies with ongoing COVID-19 investigational therapies and vaccines trials have placed a heavy emphasis on diversity, bringing the industry-wide issue to the global stage.